Montanaro Asset Management Ltd Has $22.49 Million Stake in Balchem Co. (NASDAQ:BCPC)

Montanaro Asset Management Ltd decreased its holdings in Balchem Co. (NASDAQ:BCPC) by 14.1% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 127,800 shares of the basic materials company’s stock after selling 21,000 shares during the period. Balchem comprises approximately 4.0% of Montanaro Asset Management Ltd’s investment portfolio, making the stock its 7th biggest holding. Montanaro Asset Management Ltd’s holdings in Balchem were worth $22,493,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Legacy Capital Wealth Partners LLC bought a new position in shares of Balchem in the third quarter valued at about $232,000. Atria Investments Inc grew its stake in Balchem by 8.5% in the 3rd quarter. Atria Investments Inc now owns 2,708 shares of the basic materials company’s stock valued at $477,000 after buying an additional 212 shares during the last quarter. Fiera Capital Corp bought a new position in Balchem in the 3rd quarter valued at about $4,201,000. Portside Wealth Group LLC lifted its position in Balchem by 12.5% during the third quarter. Portside Wealth Group LLC now owns 1,551 shares of the basic materials company’s stock worth $273,000 after acquiring an additional 172 shares during the last quarter. Finally, QRG Capital Management Inc. boosted its holdings in shares of Balchem by 16.3% during the third quarter. QRG Capital Management Inc. now owns 5,186 shares of the basic materials company’s stock worth $913,000 after acquiring an additional 728 shares during the period. 87.91% of the stock is owned by institutional investors and hedge funds.

Balchem Price Performance

Shares of Balchem stock opened at $179.32 on Friday. The company has a quick ratio of 1.90, a current ratio of 2.98 and a debt-to-equity ratio of 0.21. The stock has a market capitalization of $5.83 billion, a price-to-earnings ratio of 48.20, a price-to-earnings-growth ratio of 5.48 and a beta of 0.65. Balchem Co. has a twelve month low of $116.84 and a twelve month high of $186.03. The company has a 50-day simple moving average of $172.12 and a two-hundred day simple moving average of $164.24.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on the company. StockNews.com upgraded Balchem from a “hold” rating to a “buy” rating in a research note on Monday, October 28th. HC Wainwright increased their price objective on Balchem from $185.00 to $190.00 and gave the stock a “buy” rating in a research report on Monday, November 4th.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.